Clinical approach to an 1) respiratory case( within the spectrum of bronchiectasis, consolidation, pleural effusion) 2) cvs case (as,ar,ms,mr)

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Here is a comprehensive clinical approach to both systems, structured the way you would present a case at the bedside or in an exam.

PART 1 — RESPIRATORY CASE

Universal Respiratory Approach (First, apply to all three)

History

  • Presenting complaint: cough (productive/dry, duration, amount of sputum, colour), breathlessness (NYHA grade), haemoptysis, fever, weight loss, night sweats, chest pain
  • Past history: TB, recurrent pneumonias, immunosuppression, cardiac disease, malignancy
  • Occupational/travel/exposure history
  • Drug history: ACE inhibitors → dry cough; immunosuppressants → opportunistic infection
  • Smoking history (pack-years)

Examination Framework

  1. General: pallor, cyanosis (central/peripheral), clubbing, lymphadenopathy, nutritional status
  2. Vital signs: RR, SpO₂, temperature, HR, BP
  3. Hands: clubbing, peripheral cyanosis, tar staining, flap (CO₂ retention)
  4. Face: Horner's (Pancoast), plethora (SVC obstruction), anaemia
  5. Neck: tracheal position (midline/deviated), JVP, lymph nodes
  6. Chest:
StepTechniqueWhat you seek
InspectionChest shape, movement symmetry, use of accessory muscles, scarsBarrel chest, asymmetry, kyphoscoliosis
PalpationTrachea, expansion, tactile vocal fremitus (TVF)TVF ↑ = consolidation; TVF ↓ = effusion/pneumothorax
PercussionAll zones, front + back, compare sidesDull = consolidation/effusion; Stony dull = effusion
AuscultationBreath sounds, added sounds, vocal resonanceBronchial breathing, crackles, wheeze, reduced BS

1. BRONCHIECTASIS

Pathophysiology

Irreversible dilatation of bronchi from chronic inflammation → mucociliary dysfunction → vicious cycle of infection and further damage. Common organisms: H. influenzae, S. aureus, P. aeruginosa.

Classic Presentation

  • Cough: chronic, productive of large volumes (≥30 mL/day) of mucopurulent sputum — "three-layer" sputum (frothy top, mucoid middle, purulent deposit)
  • Haemoptysis (may be massive from bronchial artery erosion)
  • Recurrent chest infections; fever during exacerbations
  • Weight loss, fatigue

Key Signs

  • Clubbing — important finding (unlike simple COPD)
  • Coarse crackles (post-tussive clearing) at lung bases
  • Wheeze may be present (associated bronchoconstriction)
  • Cyanosis in advanced disease

Investigations

InvestigationFinding
Sputum MCSIdentify pathogen; Pseudomonas = severe disease
CXRTram-track shadows (parallel bronchial wall thickening), ring shadows
HRCT chestGold standard — bronchi wider than accompanying artery (signet-ring sign), lack of tapering, mucous plugging; sensitivity 95–98%
SpirometryUsually obstructive; may be restrictive
BronchoscopyExclude endobronchial obstruction, obtain BAL
Workup for causeSweat chloride (CF), serum immunoglobulins, ABPA serology, nasal brush for cilia

Management

  • Airway clearance: chest physiotherapy, postural drainage — cornerstone
  • Antibiotics: targeted to organism; oral/IV for exacerbations
  • Long-term macrolides (azithromycin): reduce exacerbations and improve lung function
  • Inhaled β₂-agonists: improve mucociliary clearance, reverse bronchoconstriction
  • Mucolytics: hypertonic saline, dornase alfa (CF)
  • Surgery: resection for localised disease; transplant for end-stage

2. CONSOLIDATION

Pathophysiology

Air in alveoli replaced by fluid, pus, blood, or cells → lung solidifies. Most common cause: pneumonia (lobar or segmental). Others: pulmonary oedema, malignancy (broncho-alveolar carcinoma), pulmonary haemorrhage.

Classic Presentation

  • Fever, rigors, productive cough (rusty sputum in pneumococcal pneumonia), pleuritic chest pain
  • Dyspnoea; confusion (especially elderly)

Key Signs on Examination

SignConsolidationRationale
TVF/TVR↑ (increased)Solid medium conducts sound better
PercussionDullAirless tissue
Breath soundsBronchialOpen bronchus + solid lung = tracheal sound transmitted
Added soundsCoarse crackles, pleural rubAlveolar fluid, pleuritis
Vocal resonance↑ Whispering pectoriloquySolid lung amplifies whispered voice
AegophonyPresent ("ee" → "ay")At edge of consolidation

Investigations

  • CXR: homogeneous opacity in lobe/segment with air bronchogram
  • CT chest: confirms, characterises (solid vs ground-glass), detects complications (abscess, empyema)
  • Sputum and blood cultures, urine pneumococcal/Legionella antigen
  • Bloods: FBC, CRP, LFTs, ABG, procalcitonin
  • Severity scoring: CURB-65 (Confusion, Urea >7, RR ≥30, BP <90/60, Age ≥65) — score 0–5 guides admission

Management

  • Antibiotics guided by severity and likely organism (CAP → amoxicillin ± clarithromycin; HAP → broader coverage)
  • Oxygen, analgesia (pleuritic pain), hydration
  • Review at 48–72 hours; CXR at 6 weeks to confirm resolution (exclude malignancy)

3. PLEURAL EFFUSION

Classification — The Key First Step

Distinguish transudate vs exudate using Light's criteria (exudate = any of):
  • Pleural protein / serum protein > 0.5
  • Pleural LDH / serum LDH > 0.6
  • Pleural LDH > ⅔ upper limit of normal serum LDH
TransudateExudate
Mechanism↑ hydrostatic or ↓ oncotic pressureInflammation, infection, malignancy
CausesCCF, cirrhosis (hepatic hydrothorax), nephrotic syndrome, hypoalbuminaemiaPneumonia (parapneumonic), malignancy, TB, PE, autoimmune (SLE)

Classic Presentation

  • Dyspnoea (often progressive), dry cough, pleuritic pain (if exudate with pleuritis)
  • In hepatic hydrothorax: usually right-sided; may exist even without obvious ascites

Key Signs on Examination

SignPleural EffusionRationale
TracheaDeviated away (large effusion)Mediastinal shift
TVF↓ (reduced)Fluid attenuates vibration
PercussionStony dullFluid below, resonant above
Breath soundsAbsent/reducedFluid insulates lung
At upper marginBronchial breathing, aegophonyCompressed lung above effusion
Vocal resonance↓Fluid dampens sound

Investigations

  • CXR: blunting of costophrenic angle (>200 mL); meniscus sign; mediastinal shift
  • Ultrasound chest: confirms effusion, guides safe aspiration
  • Diagnostic thoracentesis: send for protein, LDH, glucose, pH, cytology, MCS, ADA (TB)
  • CT chest with contrast: pleural thickening/enhancement (malignant or TB)
  • Pleural biopsy if cytology negative

Management

  • Treat underlying cause
  • Therapeutic aspiration (thoracocentesis): symptomatic relief (drain max 1.5 L in first session to avoid re-expansion pulmonary oedema)
  • Intercostal drain + intrapleural fibrinolytics: complicated parapneumonic effusion / empyema
  • TIPS: refractory hepatic hydrothorax (70–80% initial response)
  • Pleurodesis (talc/chemical): recurrent malignant effusion
  • Indwelling pleural catheter (IPC): palliation or bridge to transplant in hepatic hydrothorax


PART 2 — CARDIOVASCULAR (VALVULAR) CASE

Universal CVS Approach

History

  • Symptoms: dyspnoea (exertional, orthopnoea, PND), palpitations, syncope/presyncope, chest pain/angina, fatigue, oedema
  • Past history: rheumatic fever (key for MS/MR), infective endocarditis, hypertension (AR), Marfan's, connective tissue disease
  • Drug/procedure history: anticoagulation, previous valvotomy/surgery
  • NYHA classification of dyspnoea

Examination Framework (Cardiovascular)

  1. General: dyspnoea at rest, malar flush (MS), Marfanoid habitus, pallor
  2. Hands: clubbing, splinter haemorrhages, Osler's nodes, Janeway lesions (endocarditis), peripheral cyanosis
  3. Pulse: rate, rhythm, volume, character (water-hammer, slow-rising, collapsing)
  4. BP: wide pulse pressure (AR), low pulse pressure (severe AS)
  5. JVP: raised in right heart failure
  6. Apex beat: character and position (displaced = volume overload; heaving = pressure overload; tapping = palpable S1 in MS)
  7. Thrills (palpable murmurs), parasternal heave (RV overload)
  8. Auscultation: S1, S2, added sounds (S3, S4, OS), murmur (timing, location, radiation, character, manoeuvres)
  9. Lung bases: crackles (left heart failure), pleural effusion
  10. Abdomen: hepatomegaly, ascites, pulsatile liver (TR)
  11. Legs: pitting oedema

1. AORTIC STENOSIS (AS)

Aetiology

  • Calcific/degenerative (most common in elderly — ~15% of >65 years have AS)
  • Congenital bicuspid AV (presents 1–2 decades earlier)
  • Rheumatic (rarely isolated)

Haemodynamics

LV outflow obstruction → ↑ afterload → concentric LVH → diastolic dysfunction → eventually systolic dysfunction.

Classic Triad of Symptoms (severe disease)

  1. Angina (myocardial O₂ demand > supply due to hypertrophy)
  2. Syncope (exercise-induced, due to fixed output + vasodilation)
  3. Heart failure / dyspnoea (worst prognosis — median survival 1–2 years if untreated)

Key Signs

SignFinding
PulseSlow-rising, plateau ("pulsus parvus et tardus") — may be absent in elderly (arterial stiffness masks this)
BPNarrow pulse pressure
ApexHeaving, non-displaced (pressure overload, concentric LVH)
S1/S2A2 diminished/absent (calcified, immobile valve)
Ejection clickIn bicuspid AV (before S1 → S2)
S4Reduced LV compliance
MurmurHarsh, crescendo-decrescendo systolic ejection murmur at aortic area (R 2nd ICS), radiates to carotids
Paradoxical splitting S2Severe AS (delayed LV emptying)

Investigations

ECGLVH (voltage criteria), strain pattern, LBBB
CXRCardiomegaly, post-stenotic aortic dilatation, calcification on lateral view
Echo (Doppler)Gold standard: valve area <1.0 cm² (severe), mean gradient ≥40 mmHg, peak velocity ≥4 m/s, LVH
Cardiac catheterisationWhen echo inconclusive; coronary anatomy pre-op

Management

  • Asymptomatic: regular surveillance echo; aggressive cardiovascular risk factor modification
  • Symptomatic severe AS: AVR (surgical or TAVR)
    • ACC/AHA 2020: Surgical AVR or TAVR with shared decision-making in symptomatic patients 65–80 years
    • TAVR preferred in patients >80 or high surgical risk
  • Low-flow, low-gradient AS: assess with dobutamine stress echo
  • Tissue valve preferred in elderly (avoid anticoagulation)
  • No medical therapy proven to alter natural history — vasodilators/nitrates are relatively contraindicated (↓ preload → syncope)

2. AORTIC REGURGITATION (AR)

Aetiology

  • Valvular: degenerative calcification, infective endocarditis, rheumatic, bicuspid AV
  • Aortic root: hypertension (annular dilation), Marfan's syndrome, aortic dissection, syphilitic aortitis, trauma

Haemodynamics

LV volume overloaded (systolic + diastolic) → eccentric LVH → LV dilation → eventually systolic dysfunction.

Classic Features

  • Long asymptomatic period; once HF develops: 2-year survival without surgery (especially elderly)
  • Dyspnoea, palpitations (bounding pulse), nocturnal angina

Eponymous Signs (AR is rich in clinical signs)

SignDescription
Corrigan's pulseCollapsing/water-hammer pulse (rapid upstroke + collapse)
de Musset's signHead bobbing with pulse
Quincke's signCapillary pulsation in fingernails
Duroziez's signFemoral artery: systolic + diastolic bruits on compression
Traube's sign"Pistol shot" sounds over femoral artery
Müller's signVisible pulsation of uvula
Hill's signPopliteal SBP exceeds brachial SBP by >20 mmHg
Widened pulse pressure(less reliable in elderly — arterial stiffness)

Key Signs (Examination)

SignFinding
PulseCollapsing (water-hammer)
ApexDisplaced (volume overload, eccentric LVH), hyperdynamic
MurmurEarly diastolic, high-pitched, blowing at lower left sternal border (valvular) or upper right sternal border (root disease); patient sitting forward, end-expiration
Austin Flint murmurMid-diastolic rumble at apex (anterior MV leaflet buffeted by AR jet)
S3Volume-overloaded LV

Investigations

  • Echo Doppler: quantify regurgitant jet (vena contracta, regurgitant volume/fraction), LV dimensions and EF — guides timing of surgery
  • CXR: cardiomegaly, boot-shaped heart, dilated aorta, pulmonary venous congestion
  • ECG: LVH, volume overload pattern

Management

  • Vasodilators (nifedipine, ACE inhibitors): reduce afterload, symptom palliation — useful bridge if not yet surgical candidate
  • Surgery (AVR) indications:
    • Symptomatic severe AR
    • Asymptomatic: LV systolic dimension >45 mm or LVEF <50%
  • TAVR emerging in high-risk patients with severe AR (small series show success)

3. MITRAL STENOSIS (MS)

Aetiology

  • Rheumatic heart disease — overwhelmingly dominant cause worldwide
  • Congenital MS; calcific MS (elderly women with mitral annular calcification)
  • Degenerative rare (severe MAC can produce MS)

Haemodynamics

Mitral valve area ↓ (normal 4–6 cm²; symptomatic <2 cm²; severe <1 cm²) → ↑ left atrial pressure → pulmonary venous hypertension → pulmonary arterial hypertension → RV failure. Left atrial enlargement → AF → thromboembolism/stroke.

Classic Presentation

  • Dyspnoea, orthopnoea, PND (pulmonary oedema)
  • Haemoptysis (pulmonary venous hypertension → ruptured vessels)
  • Palpitations/AF: LA enlargement is the most common arrhythmia substrate
  • Stroke: AF + LA enlargement → LAA thrombus
  • Malar flush (mitral facies): peripheral vasoconstriction + low CO

Key Signs

SignFinding
PulseIrregularly irregular (AF), low volume
Malar flushPresent
JVPRaised (right heart failure, PH)
ApexTapping (palpable loud S1), undisplaced (no volume overload of LV)
Parasternal heaveRV overload (pulmonary hypertension)
S1Loud, snapping (early disease, mobile leaflet)
Opening snap (OS)After S2; shorter S2–OS interval = more severe (higher LA pressure)
MurmurLow-pitched, rumbling mid-diastolic at apex, heard best in left lateral decubitus, with bell at low pressure; pre-systolic accentuation (in sinus rhythm, atrial kick)
Graham Steell murmurEarly diastolic murmur at left sternal edge (pulmonary regurgitation from PH)
P2 loudPulmonary hypertension

Severity Assessment

  • Mild: MVA >1.5 cm², mean gradient <5 mmHg
  • Moderate: MVA 1–1.5 cm²
  • Severe: MVA <1 cm², mean gradient ≥10 mmHg, PHT ≥220 ms

Investigations

  • Echo: defines MVA (PHT method, planimetry), valve morphology, calcification, gradient, PAP — essential before any intervention
  • CXR: double contour right heart border (LA enlargement), elevated left main bronchus, Kerley B lines, pulmonary venous congestion, calcification of mitral valve
  • ECG: P mitrale (broad, bifid P), AF, RV hypertrophy (if PH)

Management

  • Rate control in AF (beta-blockers, digoxin); anticoagulation (AF or prior emboli — warfarin preferred over NOAC for RHD-AF)
  • Diuretics for congestion
  • Intervention (severe symptomatic MS):
    • Percutaneous balloon mitral valvuloplasty (PBMV): preferred if pliable, non-calcified leaflets, no significant MR — Wilkins score ≤8 = good candidate
    • Mitral valve replacement (MVR): if leaflets calcified/distorted, significant MR, or PBMV fails — perioperative mortality ≥10% in elderly

4. MITRAL REGURGITATION (MR)

Classification

  • Primary (organic) MR: leaflet/chordal/papillary muscle pathology
    • MVP (most common in developed world), rheumatic, endocarditis, chordal rupture, trauma
  • Secondary (functional) MR: normal leaflets, but annular dilation (DCM, ischaemia) or papillary muscle dysfunction (ischaemia, post-MI)

Haemodynamics

Systolic backflow → LA volume overload + LV volume overload → eccentric LVH → LA dilatation → AF → eventually LV dysfunction.

Classic Presentation

  • Fatigue, exertional dyspnoea (↓ forward CO)
  • Palpitations (AF)
  • Acute MR (chordal rupture, papillary muscle rupture in MI): flash pulmonary oedema, haemodynamic collapse

Key Signs

SignFinding
PulseAF (common), low volume in severe MR
ApexDisplaced laterally (volume overload, eccentric LVH), hyperdynamic
S1Soft/absent (valve does not close fully)
S3Volume-overloaded LV (not necessarily failure)
MurmurPansystolic (holosystolic), blowing at apex, radiates to axilla (or to back in posterior leaflet prolapse); best heard in left lateral decubitus
In MVP:Mid-systolic click followed by late systolic murmur — click moves earlier with standing/Valsalva (↓ preload → MVP occurs sooner)

Investigations

  • Echo Doppler: quantifies regurgitant volume, vena contracta, EROA; LV dimensions + EF — critical for timing surgery
    • Surgery triggered: LVEF <60% or LV end-systolic diameter >40 mm (even if asymptomatic)
  • CXR: cardiomegaly, LA enlargement, pulmonary oedema
  • ECG: P mitrale, AF, LVH
  • TEE/3D echo: surgical planning, especially for repair

Management

  • Primary MR: surgical MV repair preferred over replacement when feasible (lower mortality, better LV function preservation); repair recommended even in asymptomatic severe MR if LVEF <60% or LV ESD >40 mm
  • Secondary (functional) MR:
    • Optimise GDMT for HF (ACE inhibitor/ARB, beta-blocker, MRA)
    • TEER (MitraClip): IIa recommendation in symptomatic severe secondary MR meeting COAPT criteria (LVEF 20–50%, GDMT-optimised) — FDA approved 2019
  • AF: rate control + anticoagulation

Quick Differentiating Table — Valvular Murmurs

ValveMurmurTimingSiteRadiationKey Associated Findings
ASCrescendo-decrescendo, harshSystolic (ejection)Aortic (R 2nd ICS)CarotidsSlow-rising pulse, ↓A2, S4, heaving non-displaced apex
ARHigh-pitched, blowingEarly diastolicLower LSB—Collapsing pulse, displaced hyperdynamic apex, Austin Flint murmur, S3, wide PP
MSLow-pitched, rumblingMid-diastolic (+pre-systolic)Apex (bell, lateral decubitus)NoneTapping apex, loud S1, OS, malar flush, AF, parasternal heave
MRBlowing, pansystolicSystolicApexAxillaSoft S1, S3, displaced apex, AF

Quick Differentiating Table — Respiratory Signs

ConditionTVFPercussionBSAdded soundsTrachea
Consolidation↑DullBronchialCrackles, pleural rubCentral (unless large)
Pleural effusion↓Stony dullAbsent / ↓Absent (bronchial at top margin)Away from effusion (large)
BronchiectasisNormal/↑NormalCoarse crackles, wheezePost-tussive clearing cracklesCentral
Pneumothorax↓Hyper-resonantAbsentNoneAway from PTX (tension)

*Sources: Murray & Nadel's Textbook of Respiratory Medicine; Braunwald's Heart Disease (2-Volume Set, A Textbook of Cardiovascular Medicine)*The above covers both cases in exam/bedside format. A few key points to drill:

High-yield mnemonics/anchors:
RESPIRATORY — the 3-sign cluster:
  • Consolidation = TVF ↑ + Dull + Bronchial breathing (all three together)
  • Effusion = TVF ↓ + Stony dull + Absent BS (with bronchial breathing only at the compressed upper margin)
  • Bronchiectasis = Clubbing + Coarse crackles + Post-tussive clearing + 3-layer sputum
CVS — the 3-symptom triad of AS (angina → syncope → failure = 5, 3, 2 year survival untreated respectively) is a classic exam point.
AR vs MR murmur distinction:
  • AR = early diastolic, lower left sternal border, collapsing pulse
  • MR = pansystolic, apex → axilla, displaced apex
MS severity = S2–OS interval: shorter interval = higher LA pressure = more severe. Opening snap disappears when leaflets become immobile (heavily calcified).
MR timing of surgery: the "60/40 rule" — operate before LVEF drops below 60% or LV end-systolic diameter exceeds 40 mm, even if still asymptomatic.
This is a shared conversation. Sign in to Orris to start your own chat.